Galenea galenea.com


Public list: Pharma Startups (4740) Neuroscience Startups (942)

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, Automated NeuroTRansmission Assay) system, which enables direct high throughput screening of synaptic function in cultured primary neurons from mice and rats, and in neurons derived from human induced pluripotent stem cells. The company is using the MANTRA system to characterize synaptic dysfunctions...Show all

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, Automated NeuroTRansmission Assay) system, which en...Show all

Company (Alive / Active)

Phone: 617-374-1010

Fax:

300 Technology Square
2nd Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Galenea $11.5M Apr 26, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Galenea Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Memory Pharmaceuticals

Montvale, New Jersey, United States
AcquiredMemory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.Login to see details

Avera Pharmaceuticals

San Diego, California, United States
Dead / InactiveAvera is a development stage biotechnology company developing drugs to treat diseases of the central nervous systemAvera PharmaceuticalsLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compounds and methods of use thereof Aug 10, 2010 Dec 16, 2014 Patent
Indole compounds useful as serotonin selective agents Dec 14, 2009 Dec 06, 2011 Patent
Substituted arylamine compounds and methods of treatment Jan 25, 2006 Jun 28, 2011 Patent
Signatures of electroencephalographic oscillations Sep 25, 2015 Application